文献速递糖尿病

1型糖尿病患者递增肾上腺素输注期间心脏自主神经病变对心脏复极化的影响

Influence of cardiac autonomic neuropathy on cardiac repolarisation during incremental adrenaline infusion in type 1 diabetes.
PubMed 文献 · Diabetologia · 2020-02-07

研究比较1型糖尿病伴自主神经功能正常、亚临床自主神经病变和确诊心脏自主神经病变者在递增肾上腺素输注下的心脏复极化。结果显示,确诊心脏自主神经病变组在较低肾上腺素浓度下即出现复极化指标异常,作者认为可能与去神经性肾上腺素能超敏有关,此类个体在应激或低血糖等生理性交感肾上腺刺激下可能心律失常风险更高。

要点

  • 确诊心脏自主神经病变组在较低肾上腺素浓度下T波振幅和对称性比值下降更早、更明显。
  • 肾上腺素输注期间各组心率升高程度不同,确诊心脏自主神经病变组最大升高幅度大于其他两组。
  • 各组QTc随肾上腺素输注均延长且程度相当,最长QTc组间比较未达统计学显著。

核心结论

  • 确诊心脏自主神经病变的参与者部分复极化指标在较低肾上腺素浓度下即出现异常,可能归因于去神经性肾上腺素能超敏;此类个体在应激或低血糖等生理性交感肾上腺刺激下可能心律失常风险更高。

研究设计与样本

  • 研究纳入10例自主神经功能正常且压力感受器敏感试验正常者(NAF)、7例亚临床自主神经病变者(SAN,标准自主神经功能试验正常而压力感受器敏感试验异常)和5例确诊心脏自主神经病变者(CAN,标准自主神经功能试验和压力感受器试验均异常),均接受递增肾上腺素输注。
  • 第一小时输注生理盐水(0.9% NaCl),第二小时和第三小时分别输注0.01 μg kg-1 min-1和0.03 μg kg-1 min-1肾上腺素,最后30分钟输注0.06 μg kg-1 min-1。
  • 每30分钟进行高分辨率心电图监测QTc时长、心室复极化参数(T波振幅、T波面积对称性比值)并采血检测钾和儿茶酚胺。

主要发现

  • 基线心率NAF组为68(95%CI 60,76)次/分,SAN组为73(59,87)次/分,CAN组为84(78,91)次/分。
  • 肾上腺素输注期间心率升高在各组间不同(p=0.01),CAN组较基线最大升高22(13,32)次/分,NAF组为11(7,15)次/分,SAN组为10(3,18)次/分。
  • 基线QTc NAF组为382(95%CI 374,390)ms,SAN组为378(363,393)ms,CAN组为392(367,417)ms(p=0.31)。
  • 各组QTc随肾上腺素输注均延长且程度相当,最长QTc NAF组为444(422,463)ms,SAN组为422(402,437)ms,CAN组为470(402,519)ms(p=0.09)。
  • 与NAF和SAN组相比,CAN组T波振幅和T波对称性比值下降更早、最大下降出现于更低肾上腺素浓度;对称性比值曲线下面积组间不同且CAN组最低(p=0.04);血浆肾上腺素升高和钾下降在各组相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We examined the effect of a standardised sympathetic stimulus, incremental adrenaline (epinephrine) infusion on cardiac repolarisation in individuals with type 1 diabetes with normal autonomic function, subclinical autonomic neuropathy and established autonomic neuropathy. METHODS: Ten individuals with normal autonomic function and baroreceptor sensitivity tests (NAF), seven with subclinical autonomic neuropathy (SAN; normal standard autonomic function tests and abnormal baroreceptor sensitivity tests); and five with established cardiac autonomic neuropathy (CAN; abnormal standard autonomic function and baroreceptor tests) underwent an incremental adrenaline infusion. Saline (0.9% NaCl) was infused for the first hour followed by 0.01 μg kg-1 min-1 and 0.03 μg kg-1 min-1 adrenaline for the second and third hours, respectively, and 0.06 μg kg-1 min-1 for the final 30 min. High resolution ECG monitoring for QTc duration, ventricular repolarisation parameters (T wave amplitude, T wave area symmetry ratio) and blood sampling for potassium and catecholamines was performed every 30 min. RESULTS: Baseline heart rate was 68 (95% CI 60, 76) bpm for the NAF group, 73 (59, 87) bpm for the SAN group and 84 (78, 91) bpm for the CAN group. During adrenaline infusion the heart rate increased differently across the groups (p = 0.01). The maximum increase from baseline (95% CI) in the CAN group was 22 (13, 32) bpm compared with 11 (7, 15) bpm in the NAF and 10 (3, 18) bpm in the SAN groups. Baseline QTc was 382 (95% CI 374, 390) ms in the NAF, 378 (363, 393) ms in the SAN and 392 (367, 417) ms in the CAN groups (p = 0.31). QTc in all groups lengthened comparably with adrenaline infusion. The longest QTc was 444 (422, 463) ms (NAF), 422 (402, 437) ms (SAN) and 470 (402, 519) ms (CAN) (p = 0.09). T wave amplitude and T wave symmetry ratio decreased and the maximum decrease occurred earlier, at lower infused adrenaline concentrations in the CAN group compared with NAF and SAN groups. AUC for the symmetry ratio was different across the groups and was lowest in the CAN group (p = 0.04). Plasma adrenaline rose and potassium fell comparably in all groups. CONCLUSIONS/INTERPRETATION: Participants with CAN showed abnormal repolarisation in some measures at lower adrenaline concentrations. This may be due to denervation adrenergic hypersensitivity. Such individuals may be at greater risk of cardiac arrhythmias in response to physiological sympathoadrenal challenges such as stress or hypoglycaemia.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Bernjak A, Chow E, Robinson EJ, et al. Influence of cardiac autonomic neuropathy on cardiac repolarisation during incremental adrenaline infusion in type 1 diabetes. Diabetologia. 2020. PMID: 32030469. doi:10.1007/s00125-020-05106-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。